---
title: "INKON Life: AI devices and systems have been gradually applied in the hospitals under the company"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/224257540.md"
description: "INKON Life stated in an institutional research on January 7th that it has applied AI devices and systems in its hospitals, covering eight major scenarios to enhance diagnostic capabilities and operational efficiency. Through dual image reading by AI and doctors, the detection rate of pulmonary nodules has increased by 32%. In the future, the company will continue to explore innovative applications of AI technology in the medical field and increase investment to promote the development of the entire tumor industry chain"
datetime: "2025-01-08T01:52:20.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/224257540.md)
  - [en](https://longbridge.com/en/news/224257540.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/224257540.md)
---

# INKON Life: AI devices and systems have been gradually applied in the hospitals under the company

INKON Life stated during an institutional research on January 7 that the company is actively exploring AI + clinical innovation applications to empower diagnostic and treatment services. Currently, AI devices and systems have been gradually implemented in the hospitals under the company, covering eight major scenarios: 3D visualization scenario, imaging diagnosis scenario, case generation scenario, radiation therapy scenario, intelligent follow-up scenario, intelligent guidance scenario, intelligent decision support scenario, and intrinsic quality control scenario, helping to enhance the hospital's diagnostic capabilities, experience levels, and operational efficiency; in terms of diagnostic capabilities, the dual reading of images by AI + doctors has improved the detection rate of pulmonary nodules by 32%; in terms of experience levels, 3D reconstruction makes treatment visualized, facilitating communication between doctors and patients as well as surgical simulation. In the future, INKON Life will continue to explore innovative applications of AI technology in clinical and device fields, continuously increase investment in the healthcare sector, and build intrinsic core competitiveness, accelerating the layout and development of the entire industry chain for tumor pre-diagnosis/treatment/recovery

### Related Stocks

- [300143.CN](https://longbridge.com/en/quote/300143.CN.md)
- [002622.CN](https://longbridge.com/en/quote/002622.CN.md)
- [300253.CN](https://longbridge.com/en/quote/300253.CN.md)
- [01833.HK](https://longbridge.com/en/quote/01833.HK.md)
- [688139.CN](https://longbridge.com/en/quote/688139.CN.md)
- [002589.CN](https://longbridge.com/en/quote/002589.CN.md)
- [002432.CN](https://longbridge.com/en/quote/002432.CN.md)
- [300288.CN](https://longbridge.com/en/quote/300288.CN.md)
- [301235.CN](https://longbridge.com/en/quote/301235.CN.md)
- [00241.HK](https://longbridge.com/en/quote/00241.HK.md)
- [02158.HK](https://longbridge.com/en/quote/02158.HK.md)

## Related News & Research

- [11:06 ETEndurance Named to Inc. 5000 for 11th Time, Continuing National Growth](https://longbridge.com/en/news/296124358.md)
- [CSPC Innovation Pharmaceutical: Biopharma licensing and product launches drove record revenue and profit growth](https://longbridge.com/en/news/296129143.md)
- [08:48 ETLanguageLine TranslateExpress Now Available in the Epic Toolbox](https://longbridge.com/en/news/296230987.md)
- [Dicot Pharma submits EU clinical trial application for LIB-01 phase 2b study](https://longbridge.com/en/news/296068059.md)
- [CataCap buys majority stake in Danish data protection provider B4Restore](https://longbridge.com/en/news/296194758.md)